MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...

More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...

The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...

Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.

AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Mérieux Equity Partners has outlined its approach to investing in Lithuania and wider Europe, highlighting a particular focus ...

Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

Bucking the trend of IL-12 therapy programme failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...

Share price in Harmony tumbled in the wake of the Phase III trial miss, with a route to market for ZYN002 looking bleak.